Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center

Objectives Early identification of SARS-CoV-2 infection is important to guide quarantine and reduce transmission. This study evaluates the diagnostic performance of lung ultrasound (LUS), an affordable, consumable-free point-of-care tool, for COVID-19 screening.Design, setting and participants This...

Full description

Saved in:
Bibliographic Details
Main Authors: Olivier Hugli, Jean-Yves Meuwly, Noémie Boillat-Blanco, Pierre-Nicolas Carron, Siméon Schaad, Thomas Brahier, Mary-Anne Hartley, Jean-Baptiste Cordonnier, Luca Bosso, Tanguy Espejo, Olivier Pantet
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e060181.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583833917063168
author Olivier Hugli
Jean-Yves Meuwly
Noémie Boillat-Blanco
Pierre-Nicolas Carron
Siméon Schaad
Thomas Brahier
Mary-Anne Hartley
Jean-Baptiste Cordonnier
Luca Bosso
Tanguy Espejo
Olivier Pantet
author_facet Olivier Hugli
Jean-Yves Meuwly
Noémie Boillat-Blanco
Pierre-Nicolas Carron
Siméon Schaad
Thomas Brahier
Mary-Anne Hartley
Jean-Baptiste Cordonnier
Luca Bosso
Tanguy Espejo
Olivier Pantet
author_sort Olivier Hugli
collection DOAJ
description Objectives Early identification of SARS-CoV-2 infection is important to guide quarantine and reduce transmission. This study evaluates the diagnostic performance of lung ultrasound (LUS), an affordable, consumable-free point-of-care tool, for COVID-19 screening.Design, setting and participants This prospective observational cohort included adults presenting with cough and/or dyspnoea at a SARS-CoV-2 screening centre of Lausanne University Hospital between 31 March and 8 May 2020.Interventions Investigators recorded standardised LUS images and videos in 10 lung zones per patient. Two blinded independent experts reviewed LUS recording and classified abnormal findings according to prespecified criteria to investigate their predictive value to diagnose SARS-CoV-2 infection according to PCR on nasopharyngeal swabs (COVID-19 positive vs COVID-19 negative).Primary and secondary outcome measures We finally combined LUS and clinical findings to derive a multivariate logistic regression diagnostic score.Results Of 134 included patients, 23% (n=30/134) were COVID-19 positive and 77% (n=103/134) were COVID-19 negative; 85%, (n=114/134) cases were previously healthy healthcare workers presenting within 2–5 days of symptom onset (IQR). Abnormal LUS findings were significantly more frequent in COVID-19 positive compared with COVID-19 negative (45% vs 26%, p=0.045) and mostly consisted of focal pathologic B lines. Combining clinical findings in a multivariate logistic regression score had an area under the receiver operating curve of 80.3% to detect COVID-19, and slightly improved to 84.5% with the addition of LUS features.Conclusions COVID-19-positive patients are significantly more likely to have lung pathology by LUS. However, LUS has an insufficient sensitivity and is not an appropriate screening tool in outpatients. LUS only adds little value to clinical features alone.
format Article
id doaj-art-14fed94ce7ad4093aed64e6dba400a89
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-14fed94ce7ad4093aed64e6dba400a892025-01-28T03:45:11ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-060181Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening centerOlivier Hugli0Jean-Yves Meuwly1Noémie Boillat-Blanco2Pierre-Nicolas Carron3Siméon Schaad4Thomas Brahier5Mary-Anne Hartley6Jean-Baptiste Cordonnier7Luca Bosso8Tanguy Espejo9Olivier Pantet102 Emergency Department, Lausanne University Hospital, University of Lausanne, Lausanne, SwitzerlandDepartment of Radiology, Lausanne University Hospital, Lausanne, SwitzerlandInfectious Diseases Service, Lausanne University Hospital, Lausanne, SwitzerlandEmergency Department, Lausanne University Hospital, Lausanne, SwitzerlandInfectious Diseases Service, University Hospital of Lausanne, Lausanne, SwitzerlandInfectious Diseases, CHUV, Lausanne, SwitzerlandDigital Global Health Department, University of Lausanne, Lausanne, SwitzerlandMachine Learning and Optimization Laboratory, EPFL, Lausanne, SwitzerlandEmergency Department, Lausanne University Hospital Emergency Care Service, Lausanne, SwitzerlandEmergency Department, Lausanne University Hospital Emergency Care Service, Lausanne, SwitzerlandAdult Intensive Care Unit, Lausanne University Hospital, Lausanne, SwitzerlandObjectives Early identification of SARS-CoV-2 infection is important to guide quarantine and reduce transmission. This study evaluates the diagnostic performance of lung ultrasound (LUS), an affordable, consumable-free point-of-care tool, for COVID-19 screening.Design, setting and participants This prospective observational cohort included adults presenting with cough and/or dyspnoea at a SARS-CoV-2 screening centre of Lausanne University Hospital between 31 March and 8 May 2020.Interventions Investigators recorded standardised LUS images and videos in 10 lung zones per patient. Two blinded independent experts reviewed LUS recording and classified abnormal findings according to prespecified criteria to investigate their predictive value to diagnose SARS-CoV-2 infection according to PCR on nasopharyngeal swabs (COVID-19 positive vs COVID-19 negative).Primary and secondary outcome measures We finally combined LUS and clinical findings to derive a multivariate logistic regression diagnostic score.Results Of 134 included patients, 23% (n=30/134) were COVID-19 positive and 77% (n=103/134) were COVID-19 negative; 85%, (n=114/134) cases were previously healthy healthcare workers presenting within 2–5 days of symptom onset (IQR). Abnormal LUS findings were significantly more frequent in COVID-19 positive compared with COVID-19 negative (45% vs 26%, p=0.045) and mostly consisted of focal pathologic B lines. Combining clinical findings in a multivariate logistic regression score had an area under the receiver operating curve of 80.3% to detect COVID-19, and slightly improved to 84.5% with the addition of LUS features.Conclusions COVID-19-positive patients are significantly more likely to have lung pathology by LUS. However, LUS has an insufficient sensitivity and is not an appropriate screening tool in outpatients. LUS only adds little value to clinical features alone.https://bmjopen.bmj.com/content/12/6/e060181.full
spellingShingle Olivier Hugli
Jean-Yves Meuwly
Noémie Boillat-Blanco
Pierre-Nicolas Carron
Siméon Schaad
Thomas Brahier
Mary-Anne Hartley
Jean-Baptiste Cordonnier
Luca Bosso
Tanguy Espejo
Olivier Pantet
Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center
BMJ Open
title Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center
title_full Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center
title_fullStr Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center
title_full_unstemmed Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center
title_short Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center
title_sort point of care lung ultrasonography for early identification of mild covid 19 a prospective cohort of outpatients in a swiss screening center
url https://bmjopen.bmj.com/content/12/6/e060181.full
work_keys_str_mv AT olivierhugli pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT jeanyvesmeuwly pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT noemieboillatblanco pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT pierrenicolascarron pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT simeonschaad pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT thomasbrahier pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT maryannehartley pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT jeanbaptistecordonnier pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT lucabosso pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT tanguyespejo pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter
AT olivierpantet pointofcarelungultrasonographyforearlyidentificationofmildcovid19aprospectivecohortofoutpatientsinaswissscreeningcenter